These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 21295029)
41. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives. Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262 [TBL] [Abstract][Full Text] [Related]
42. Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization. Vlachodimitropoulou Koumoutsea E; Garbowski M; Porter J Br J Haematol; 2015 Sep; 170(6):874-83. PubMed ID: 26033030 [TBL] [Abstract][Full Text] [Related]
43. Pharmacomodulation on the 3-acetylursolic acid skeleton: Design, synthesis, and biological evaluation of novel N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-acetylursolamide derivatives as antimalarial agents. Gnoatto SC; Susplugas S; Dalla Vechia L; Ferreira TB; Dassonville-Klimpt A; Zimmer KR; Demailly C; Da Nascimento S; Guillon J; Grellier P; Verli H; Gosmann G; Sonnet P Bioorg Med Chem; 2008 Jan; 16(2):771-82. PubMed ID: 17967541 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Loria P; Miller S; Foley M; Tilley L Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):363-70. PubMed ID: 10191268 [TBL] [Abstract][Full Text] [Related]
45. Definition of an electronic profile of compounds with inhibitory activity against hematin aggregation in malaria parasite. Portela C; Afonso CM; Pinto MM; Ramos MJ Bioorg Med Chem; 2004 Jun; 12(12):3313-21. PubMed ID: 15158799 [TBL] [Abstract][Full Text] [Related]
46. Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin. Kalkanidis M; Klonis N; Tilley L; Deady LW Biochem Pharmacol; 2002 Mar; 63(5):833-42. PubMed ID: 11911834 [TBL] [Abstract][Full Text] [Related]
47. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism. He Z; Chen L; You J; Qin L; Chen X Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959 [TBL] [Abstract][Full Text] [Related]
48. The mechanism of antimalarial action of [Au(CQ)(PPh(3))]PF(6): structural effects and increased drug lipophilicity enhance heme aggregation inhibition at lipid/water interfaces. Navarro M; Castro W; Martínez A; Sánchez Delgado RA J Inorg Biochem; 2011 Feb; 105(2):276-82. PubMed ID: 21194628 [TBL] [Abstract][Full Text] [Related]
49. In vitro antimalarial effect of daphnetin relating to its iron-chelating activity. Mu LY; Wang QM; Ni YC Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(2):83-5. PubMed ID: 12567565 [TBL] [Abstract][Full Text] [Related]
50. A physiochemical mechanism of hemozoin (beta-hematin) synthesis by malaria parasite. Tripathi AK; Garg SK; Tekwani BL Biochem Biophys Res Commun; 2002 Jan; 290(1):595-601. PubMed ID: 11779214 [TBL] [Abstract][Full Text] [Related]
51. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. Piga A; Galanello R; Forni GL; Cappellini MD; Origa R; Zappu A; Donato G; Bordone E; Lavagetto A; Zanaboni L; Sechaud R; Hewson N; Ford JM; Opitz H; Alberti D Haematologica; 2006 Jul; 91(7):873-80. PubMed ID: 16818273 [TBL] [Abstract][Full Text] [Related]
52. In vitro antiplasmodial activity of prenylated chalcone derivatives of hops (Humulus lupulus) and their interaction with haemin. Frölich S; Schubert C; Bienzle U; Jenett-Siems K J Antimicrob Chemother; 2005 Jun; 55(6):883-7. PubMed ID: 15824094 [TBL] [Abstract][Full Text] [Related]
53. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311. Chaston TB; Lovejoy DB; Watts RN; Richardson DR Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494 [TBL] [Abstract][Full Text] [Related]